The WHO has declared the Bundibugyo Ebola strain a global health emergency for the first time. With hundreds of suspected cases, no approved treatment, and an outbreak zone riven by conflict and displacement, the window for containment may already be closing.
In the Mongbwalu health zone of the DRC’s Ituri Province, a region already fractured by decades of conflict and mining-driven displacement, health workers began noticing something wrong in late April. Patients were presenting with fever, intense body pain, vomiting, and in a number of cases, bleeding. Several deteriorated and died within days. Laboratory analysis would later confirm what officials had feared: the Bundibugyo ebolavirus, a rare and poorly understood strain of Ebola for which no licensed vaccine or targeted treatment currently exists. By 15 May 2026, both the DRC and Uganda had formally declared outbreaks. By 17 May, the World Health Organisation had issued a Public Health Emergency of International Concern, the highest level of global health alert, reserved for outbreaks that threaten to cross borders and overwhelm national response capacity. Both conditions, in this case, had already been met.
The scale of what is unfolding is alarming and, in the view of many epidemiologists, underappreciated by the international community. As of 21 May, 746 suspected cases and 176 deaths had been reported in the DRC. Among confirmed cases, 85 individuals had tested positive across both countries, with two in Uganda and one in an American national who was subsequently transferred to Germany for specialist care. The case count is climbing daily, and health experts believe the virus may have been spreading undetected for two to three weeks before the formal declaration, meaning the true scope of transmission could be considerably wider than official figures suggest.
What makes the Bundibugyo strain particularly dangerous is precisely what distinguishes it from the Zaire strain that has dominated previous outbreaks. The vaccines that proved decisive in containing the 2018 to 2020 DRC outbreak, among them the rVSV-ZEBOV shot, do not provide protection against Bundibugyo. Ring vaccination, the strategy of immunising contacts and contacts of contacts to build a firewall around transmission chains, cannot be deployed in the way health workers have come to rely upon. Response teams are therefore working with older tools: isolation, contact tracing, community engagement, and personal protective equipment. These are effective but slow, and their effectiveness depends entirely on health workers being able to reach affected communities. In Ituri, North Kivu, and South Kivu, the provinces where transmission is concentrated, armed groups remain active, roads are damaged, and the health infrastructure was already stretched thin by years of conflict and displacement before this outbreak began.
The absence of a vaccine transforms a containable outbreak into a race against time. Every day of delayed international funding and support is a day the virus has to find new hosts.Why Uganda Signals a Turning Point
The confirmation of cases in Uganda introduces a qualitatively different phase of the outbreak. Both Ugandan cases are directly linked to travel from the DRC, and there is as yet no evidence of sustained local transmission beyond the border. But Uganda, with its high cross-border traffic, regional transport links, and history of Ebola incursions, represents a possible gateway to wider East African spread. Ugandan health authorities have activated surveillance systems and isolation facilities. The East African Community has convened an emergency public health meeting. Neighbouring countries including Kenya, Rwanda, and Tanzania have raised border screening protocols. Nevertheless, the pattern of detection, two cases identified only after the individuals had already crossed an international frontier, illustrates how easily a virus can outpace surveillance systems in environments of dense movement and limited diagnostic capacity.
The Response Gap
The WHO and its partners, including Medecins Sans Frontieres and the International Rescue Committee, are scaling up in the affected zones. But they are doing so in conditions that severely limit what is possible. The WHO’s humanitarian logistics hub in Dubai, which serves as the primary supply line for Central and East African health emergencies, is still partially disrupted by the ongoing conflict between the United States and Iran and the closure of air corridors over the Gulf. As Global Echos reported in its Invisible Crisis Edition, medical supplies for hundreds of thousands of people remain stranded in Dubai, unable to reach the populations that need them. The Ebola response is not exempt from this disruption.
Vaccine developers including Sabin Vaccine Institute and the Janssen group have indicated that Bundibugyo-specific candidates exist in early-stage pipelines, but accelerating those to emergency use authorisation will take months at minimum. For the communities of Ituri facing this outbreak today, months is not a timeline. It is a sentence. The international community declared PHEIC status in record time. What happens next will depend not on declarations, but on funding, logistics, and the willingness of donors who are already stretched across multiple simultaneous crises to respond with the speed and scale this outbreak demands.
